Skip to main content
padlock icon - secure page this page is secure

Utilizing a Quartz Crystal Microbalance for Quantifying CD4+ T Cell Counts

Buy Article:

$106.73 + tax (Refund Policy)

Acquired immune deficiency syndrome (AIDS) is a world wide epidemic. Third world countries, especially in Africa, suffer the most from AIDS. The progression of HIV/AIDS is monitored by the change in blood concentration of CD4+ T cells. However, the most common technology used to measure CD4+ counts, flow cytometry, has a high cost of capital, and is incapable of measuring in remote villages. An alternative method of measurement must be developed to help properly treat the individuals most affected in resource poor areas. In this paper, by using a self-assembled monolayer, we were able to attach anti-CD4 antibodies to the surface of a gold coated quartz crystal for use in a quartz crystal microbalance (QCM). The antibody coated QCM crystal was able to quantify the amount of CD4+ T cells in phosphate buffer solution (PBS). Furthermore, the functionalized crystal did not respond to CD4 T cell controls in identical conditions. With these results we propose that QCM technology can be used to quantify CD4+ T cells in patients who are HIVpositive.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: September 1, 2005

More about this publication?
  • The growing interest and activity in the field of sensor technologies requires a forum for rapid dissemination of important results: Sensor Letters is that forum. Sensor Letters offers scientists, engineers and medical experts timely, peer-reviewed research on sensor science and technology of the highest quality. Sensor Letters publish original rapid communications, full papers and timely state-of-the-art reviews encompassing the fundamental and applied research on sensor science and technology in all fields of science, engineering, and medicine. Highest priority will be given to short communications reporting important new scientific and technological findings.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more